The deficiency of CDC20 has been demonstrated to decrease the percentage of G0/G1 phase and increase the percentage of G2/M phase in cutaneous squamous cell carcinoma cells [39]. Here, CDC20 is linked to cutaneous squamous cell carcinoma.